JANSSEN COVID-19 VACCINE Ινδονησία - Ινδονησιακά - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

janssen covid-19 vaccine

integrated healthcare indonesia - indonesia - recombinant novel adenovirus (ad-26) vector-sars-cov-2 - suspensi injeksi - nlt 2.5 x 10^10 vp, nlt 8.92 log10 iu

GLUCOVANCE Ινδονησία - Ινδονησιακά - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

glucovance

merck tbk - indonesia - metformin hydrochloride, glibenclamide - tablet salut selaput - 250 mg /1.25 mg

GLUCOVANCE Ινδονησία - Ινδονησιακά - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

glucovance

merck tbk - indonesia - metformin hydrochloride, glibenclamide - tablet salut selaput - 500 mg /2.5 mg

GLUCOVANCE Ινδονησία - Ινδονησιακά - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

glucovance

merck tbk - indonesia - metformin hydrochloride, glibenclamide - tablet salut selaput - 500 mg /5 mg

JANSSEN COVID-19 VACCINE Ινδονησία - Ινδονησιακά - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

janssen covid-19 vaccine

integrated healthcare indonesia - indonesia - recombinant novel adenovirus (ad-26) vector-sars-cov-2 - suspensi injeksi - nlt 2.5 x 10^10 vp, nlt 8.92 log10 iu